| Author |
Title |
Year  |
Publication |
Volume |
Pages |
| Shahar, T.; Rozovski, U.; Hess, K.R.; Hossain, A.; Gumin, J.; Gao, F.; Fuller, G.N.; Goodman, L.; Sulman, E.P.; Lang, F.F. |
Percentage of mesenchymal stem cells in high-grade glioma tumor samples correlates with patient survival |
2017 |
Neuro-Oncology |
19 |
660-668 |
| Roy, A.; Attarha, S.; Weishaupt, H.; Edqvist, P.-H.; Swartling, F.J.; Bergqvist, M.; Siebzehnrubl, F.A.; Smits, A.; Ponten, F.; Tchougounova, E. |
Serglycin as a potential biomarker for glioma: association of serglycin expression, extent of mast cell recruitment and glioblastoma progression |
2017 |
Oncotarget |
8 |
24815-24827 |
| Emery, I.F.; Gopalan, A.; Wood, S.; Chow, K.-H.; Battelli, C.; George, J.; Blaszyk, H.; Florman, J.; Yun, K. |
Expression and function of ABCG2 and XIAP in glioblastomas |
2017 |
Journal of Neuro-Oncology |
133 |
47-57 |
| Batista, K.M.P.; Eulate-Beramendi, S.A. de; Pina, K.Y.A.R. de; Figueira, P.R.; Canal, A.F.; Chasin, J.M.A.; Meilan, A.; Ugalde, R.; Vega, I.F. |
Mesenchymal/proangiogenic factor YKL-40 related to glioblastomas and its relationship with the subventricular zone |
2017 |
Folia Neuropathologica |
55 |
14-22 |
| Khalifa, J.; Tensaouti, F.; Lusque, A.; Plas, B.; Lotterie, J.-A.; Benouaich-Amiel, A.; Uro-Coste, E.; Lubrano, V.; Cohen-Jonathan Moyal, E. |
Subventricular zones: new key targets for glioblastoma treatment |
2017 |
Radiation Oncology (London, England) |
12 |
67 |
